HighTower Advisors’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-22,515
Closed -$722K 3369
2021
Q2
$722K Buy
22,515
+713
+3% +$22.6K ﹤0.01% 1836
2021
Q1
$766K Buy
21,802
+8,778
+67% +$305K ﹤0.01% 1726
2020
Q4
$417K Buy
+13,024
New +$401K ﹤0.01% 1720
2018
Q1
Sell
-5,886
Closed -$269K 2299
2017
Q4
$269K Buy
+5,886
New +$232K ﹤0.01% 1753
2016
Q1
Sell
-13,310
Closed -$227K 2169
2015
Q4
$227K Buy
+13,310
New +$224K ﹤0.01% 1695
2015
Q1
Sell
-197,737
Closed -$2.84M 1670
2014
Q4
$2.84M Buy
197,737
+20,968
+12% +$282K 0.04% 465
2014
Q3
$2.4M Buy
176,769
+12,919
+8% +$180K 0.04% 483
2014
Q2
$2.21M Buy
163,850
+19,890
+14% +$263K 0.04% 536
2014
Q1
$1.93M Buy
143,960
+24,030
+20% +$333K 0.04% 526
2013
Q4
$1.99M Buy
119,930
+10,179
+9% +$159K 0.04% 462
2013
Q3
$1.82M Sell
109,751
-4,999
-4% -$78K 0.05% 440
2013
Q2
$1.45M Buy
+114,750
New +$1.5M 0.04% 478

Other funds holding PETS

HighTower Advisors's PETS Position: Q3 2021 in Review

HighTower Advisors sold out of PetMed Express (PETS) in Q3 2021, closing a stake of 22,515 shares — an estimated $722K sold.

HighTower Advisors first reported a position in PETS in Q2 2013 and held it in 12 quarters. The position peaked at $2.84M in Q4 2014. 193 funds tracked by Wall St. Rank hold PETS as of Q3 2021.

  • HighTower Advisors reported no remaining PetMed Express position as of Q3 2021 after selling out during the quarter.
  • HighTower Advisors sold 22,515 PetMed Express shares in Q3 2021, an estimated $722K.
  • HighTower Advisors first reported a position in PetMed Express in Q2 2013 and held it in 12 quarters.
  • HighTower Advisors's PetMed Express position peaked at $2.84M in Q4 2014.
  • 193 funds tracked by Wall St. Rank held PetMed Express as of Q3 2021.

Based on HighTower Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.